CDRH’s Owen Faris: New Clinical Trials Program Will Speed Up IDE Approvals
This article was originally published in The Gray Sheet
Executive Summary
In an interview with “The Gray Sheet,” CDRH’s Acting Clinical Trials Director Owen Faris discusses the device center’s new pre-market clinical trials program aimed at speeding up approval times for investigational device exemptions and increasing the number of IDE trials in the U.S.